De Clermont H - Search Results

1

Efficacy of re-challenging metastatic renal cell carcinoma with mTOR inhibitors.

Roca S, Quivy A, Gross-Goupil M, Bernhard JC, De Clermont H, Ravaud A. Roca S, et al. Among authors: de clermont h. Acta Oncol. 2011 Oct;50(7):1135-6. doi: 10.3109/0284186X.2011.592149. Epub 2011 Jul 5. Acta Oncol. 2011. PMID: 21726178 No abstract available.

2

Combination of gemcitabine and doxorubicin in rapidly progressive metastatic renal cell carcinoma and/or sarcomatoid renal cell carcinoma.

Roubaud G, Gross-Goupil M, Wallerand H, de Clermont H, Dilhuydy MS, Ravaud A. Roubaud G, et al. Among authors: de clermont h. Oncology. 2011;80(3-4):214-8. doi: 10.1159/000329078. Epub 2011 Jul 1. Oncology. 2011. PMID: 21720184

3

PET scans for decision-making in metastatic renal cell carcinoma: a single-institution evaluation.

Dilhuydy MS, Durieux A, Pariente A, de Clermont H, Pasticier G, Monteil J, Ravaud A. Dilhuydy MS, et al. Among authors: de clermont h. Oncology. 2006;70(5):339-44. doi: 10.1159/000097946. Epub 2006 Dec 12. Oncology. 2006. PMID: 17164590

4

[Quantitative imaging in uro-oncology].

Cornelis F, de Clermont H, Bernhard JC, Ravaud A, Grenier N. Cornelis F, et al. Among authors: de clermont h. Prog Urol. 2014 Jun;24(7):399-413. doi: 10.1016/j.purol.2014.02.008. Epub 2014 Apr 5. Prog Urol. 2014. PMID: 24861679 Review. French.

5

Anthracosis mimicking mediastinal lymph node metastases with 18F-FCholine in high-risk prostate cancer.

Pinaquy JB, Fernandez P, Pasticier G, Parrens M, De Clermont H. Pinaquy JB, et al. Among authors: de clermont h. Clin Nucl Med. 2015 Apr;40(4):e253-4. doi: 10.1097/RLU.0000000000000707. Clin Nucl Med. 2015. PMID: 25674859

6

Unusual lymph node metastases of prostate cancer detected by 18F-fluorocholine PET/CT.

Pinaquy JB, Allard JB, Cornelis F, Pasticier G, De Clermont H. Pinaquy JB, et al. Among authors: de clermont h. Clin Nucl Med. 2015 Apr;40(4):e255-7. doi: 10.1097/RLU.0000000000000708. Clin Nucl Med. 2015. PMID: 25674860

7

[Bladder located gastric heterotopy: a case report confronting embryology to histopathology].

Mazzola C, Balas D, Deminiere C, Grenier N, De Clermont H, Comby F, Ferriere JM, Pasticier G. Mazzola C, et al. Among authors: de clermont h. Prog Urol. 2011 Apr;21(4):296-9. doi: 10.1016/j.purol.2010.05.004. Epub 2010 Jun 29. Prog Urol. 2011. PMID: 21482407 French.

8

[PET-CT in thoracic disease].

Laffon E, de Clermont H, Bordenave L. Laffon E, et al. Among authors: de clermont h. Rev Mal Respir. 2010 Dec;27(10):1275-80. doi: 10.1016/j.rmr.2010.10.008. Epub 2010 Nov 2. Rev Mal Respir. 2010. PMID: 21163403 Review. French.

9

Feasibility of assessing [(18)F]FDG lung metabolism with late dynamic PET imaging.

Laffon E, de Clermont H, Vernejoux JM, Jougon J, Marthan R. Laffon E, et al. Among authors: de clermont h. Mol Imaging Biol. 2011 Apr;13(2):378-84. doi: 10.1007/s11307-010-0345-6. Mol Imaging Biol. 2011. PMID: 20524071

10

Is liver SUV stable over time in ¹⁸F-FDG PET imaging?

Laffon E, Adhoute X, de Clermont H, Marthan R. Laffon E, et al. Among authors: de clermont h. J Nucl Med Technol. 2011 Dec;39(4):258-63. doi: 10.2967/jnmt.111.090027. Epub 2011 Aug 30. J Nucl Med Technol. 2011. PMID: 21878481 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters